Inflammatory indicators (WBC) and liver function markers (ALT, GGT, and TBIL) also showed modest indirect effects, highlighting the roles of chronic inflammation and hepatocellular injury in the development of MASLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.